Amino acid profile alteration in age-related atrial fibrillation

Yunying Huang,Qiuzhen Lin,Yong Zhou,Jiayi Zhu,Yingxu Ma,Keke Wu,Zuodong Ning,Zixi Zhang,Na Liu,Mohan Li,Yaozhong Liu,Tao Tu,Qiming Liu
DOI: https://doi.org/10.1186/s12967-024-05028-7
IF: 8.44
2024-03-09
Journal of Translational Medicine
Abstract:Abstract Background Amino acids (AAs) are one of the primary metabolic substrates for cardiac work. The correlation between AAs and both atrial fibrillation (AF) and aging has been documented. However, the relationship between AAs and age-related AF remains unclear. Methods Initially, the plasma AA levels of persistent AF patients and control subjects were assessed, and the correlations between AA levels, age, and other clinical indicators were explored. Subsequently, the age-related AF mouse model was constructed and the untargeted myocardial metabolomics was conducted to detect the level of AAs and related metabolites. Additionally, the gut microbiota composition associated with age-related AF was detected by a 16S rDNA amplicon sequencing analysis on mouse fecal samples. Results Higher circulation levels of lysine (Student’s t-test, P = 0.001), tyrosine ( P = 0.002), glutamic acid ( P = 0.008), methionine ( P = 0.008), and isoleucine ( P = 0.014), while a lower level of glycine ( P = 0.003) were observed in persistent AF patients. The feature AAs identified by machine learning algorithms were glutamic acid and methionine. The association between AAs and age differs between AF and control subjects. Distinct patterns of AA metabolic profiles were observed in the myocardial metabolites of aged AF mice. Aged AF mice had lower levels of Betaine, L-histidine, L-alanine, L-arginine, L-Pyroglutamic acid, and L-Citrulline compared with adult AF mice. Aged AF mice also presented a different gut microbiota pattern, and its functional prediction analysis showed AA metabolism alteration. Conclusion This study provided a comprehensive network of AA disturbances in age-related AF from multiple dimensions, including plasma, myocardium, and gut microbiota. Disturbances of AAs may serve as AF biomarkers, and restoring their homeostasis may have potential benefits for the management of age-related AF.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role and mechanism of amino acids (AAs) in age - related atrial fibrillation (AF). Specifically, the study aims to analyze the changes in amino acid levels in the plasma of patients with persistent AF and their relationship with age. By constructing an age - related AF mouse model, further detect the changes in myocardial metabolites and gut microbiota to reveal the potential role of amino acids in the development of age - related AF. The research results show that the disorder of amino acids may be an important marker of age - related AF, and restoring their homeostasis may have potential benefits for managing age - related AF. ### Research Background Atrial fibrillation (AF) is the most common persistent cardiac rhythm abnormality, and its incidence increases significantly with age. Although electrophysiological, structural, and contractile remodeling are known to be important factors in the occurrence and development of AF, the role of cardiac metabolic remodeling in AF still needs to be explored in depth. As the main metabolic substrate for the heart to work, the homeostasis of amino acids affects the physiological and pathological processes of the cardiovascular system. Previous studies have shown that changes in amino acid levels are related to AF and aging, but the specific changes in amino acids in age - related AF have not been clearly defined. ### Research Methods 1. **Patient Selection**: The study included 30 patients with persistent AF and 30 control group participants, and their plasma samples were collected for amino acid detection. 2. **Mouse Model Establishment**: Male C57BL/6J mice aged 8 - 12 weeks and 13 months were used. AF models were induced by injecting acetylcholine and calcium chloride, and adult control group, adult AF group, elderly control group, and elderly AF group were set up respectively. 3. **Myocardial Non - targeted Metabolomics**: Mouse myocardial tissues were collected for non - targeted metabolomics analysis to detect the levels of amino acids and related metabolites. 4. **Gut Microbiome Analysis**: The gut microbial composition of AF mouse models was analyzed by 16S rDNA amplicon sequencing. ### Main Findings 1. **Changes in Plasma Amino Acid Levels**: The levels of lysine, tyrosine, glutamic acid, methionine, and isoleucine in the plasma of patients with persistent AF were significantly increased, while the level of glycine was significantly decreased. 2. **Machine Learning Algorithms**: Through a variety of machine learning algorithms (LASSO, SVM - RFE, Random Forest, XGBoost), the characteristic amino acids highly related to AF were screened out, mainly glutamic acid and methionine. 3. **Changes in Myocardial Metabolites**: In the myocardial metabolites of elderly AF mice, the levels of betaine, histidine, alanine, arginine, pyroglutamic acid, and citrulline were significantly lower than those in adult AF mice. 4. **Changes in Gut Microbiome**: The gut microbial diversity of elderly AF mice was significantly decreased, and the composition of the flora was significantly different from that of adult AF mice, especially the ratio changes of Bacteroidetes and Firmicutes. ### Conclusion This study provides a comprehensive network of amino acid disorders in age - related AF from multiple dimensions (plasma, myocardium, and gut microbiota). The disorder of amino acids may serve as a biomarker of AF, and restoring their homeostasis may have potential benefits for managing age - related AF.